Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine

Abstract

Three cases of immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded. Antiplatelet antibodies were present. A defect in platelet production was excluded in two children. Corticosteroid treatment was effective. Subsequent administration of other vaccines (against pollo, diphtheria, and tetanus) did not cause relapse of thrombocytopenia.